Document is current
Any future updates will be listed below
-
Authors
Peralta-Álvarez, Marco Polo https://orcid.org/0000-0003-2777-9272
Downward, Keya https://orcid.org/0009-0009-8818-7853
White, Andrew https://orcid.org/0000-0001-9481-0079
Redondo Azema, Hugo https://orcid.org/0009-0004-5361-0360
Sibley, Laura
Sarfas, Charlotte
Morrison, Alexandra
Dennis, Mike
Diaz-Santana, Delia
Harris, Stephanie A.
Li, Shuailin https://orcid.org/0000-0002-7430-1717
Puentes, Eugenia
Aguilo, Nacho https://orcid.org/0000-0001-7897-9173
Martin, Carlos https://orcid.org/0000-0003-2993-5478
Sharpe, Sally
McShane, Helen https://orcid.org/0000-0002-2126-5142
Tanner, Rachel https://orcid.org/0000-0003-3622-5984
-
Funding
Funding for this research was provided by:
Wellcome Trust (WT 206331/Z/17/Z)
- License Information
-
More Information
Article History
Received: 4 July 2024
Accepted: 22 October 2024
First Online: 20 November 2024
Competing interests
: CM, NA and EP are co-inventors on a patent on Tuberculosis Vaccines held by the University of Zaragoza and Biofabri. All other authors declare no competing interests.
